|
CN102186507A
|
|
Biodegradable proline-based polymers
|
|
US2010040664A1
|
|
Aabb-poly(depsipeptide) biodegradable polymers and methods of use
|
|
TW201039844A
|
|
Biodegradable metal-chelating polymers and vaccines
|
|
EP2274043A1
|
|
Biodegradable metal-chelating polymers and vaccines
|
|
CN102007168A
|
|
Oligo-ethylene glycol-based polymer compositions and methods of use
|
|
EP2185626A2
|
|
Cationic alpha-amino acid-containing biodegradable polymer gene transfer compositions
|
|
EP2178944A1
|
|
Biodegradable cationic polymer gene transfer compositions and methods of use
|
|
EP2178541A1
|
|
Bioabsorbable elastomeric arterial support device and methods of use
|
|
CN101678041A
|
|
Bioabsorbable elastomeric polymer networks, cross-linkers and methods of use
|
|
EP2068937A2
|
|
Polymer-stabilized liposomal compositions and methods of use
|
|
EP2056758A2
|
|
Epoxy-containing poly(ester amides) and methods of use
|
|
WO2007146119A2
|
|
Biodegradable polymer adhesion barriers
|
|
WO2007133616A2
|
|
Biodegradable water soluble polymers
|
|
CA2649672A1
|
|
Delivery of ophthalmologic agents to the exterior or interior of the eye
|
|
US2008020015A1
|
|
Bioactive wound dressings and implantable devices and methods of use
|
|
EP2004145A2
|
|
Alkylene-dicarboxylate-containing biodegradable poly(ester amides) and methods of use
|
|
EP1986685A2
|
|
Vaccine delivery compositions and methods of use
|
|
US2008160089A1
|
|
Vaccine delivery compositions and methods of use
|
|
EP1962894A2
|
|
Method for assembling a polymer-biologic delivery composition
|
|
EP1957113A2
|
|
Polymer particles for delivery of macromolecules and methods of use
|
